The JSE closed weaker while global markets were mixed as investors digested US inflation figures, while also weighing up and the economic threat of rising Covid-19 cases worldwide.
The JSE closed weaker while global markets were mixed, as investors digested US inflation figures and the economic threat of rising Covid-19 cases worldwide.
US inflation jumped 6.8% year-on-year in November to the highest rate since 1982, data showed on Friday. The figure came in slightly higher than the 6.7% Bloomberg estimate, while the consumer price index, which measures the cost of a wide-ranging basket of goods, rose 0.8% for the month...
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
JSE likely to grind higher ahead of US inflation printInvestors are awaiting the consumer price index for signs of future interest rate action
Read more »
US weekly jobless claims at 52-year low as labour market tightensSharp drop in weekly jobless claims to 184,000 comes as US economy recovers from the worst of the Covid-19 pandemic
Read more »
JSE opens to risk-off tone on Friday amid Omicron and inflation concernsThe rand slumped overnight and Asian markets are under pressure, amid reports Omicron is four times more transmissible than Delta
Read more »
US House votes to punish China over Uyghur treatmentThe US House of Representatives on Wednesday passed legislation banning imports from China's Xinjiang region over its treatment of the Uyghur Muslim minority, as tensions continue to escalate between Washington and Beijing.
Read more »
US to blacklist Chinese firm AI firm SenseTime ahead of Hong Kong IPOThe action against SenseTime is a censure for alleged human rights abuses in Xinjiang
Read more »
US authorises Pfizer COVID-19 booster for people aged 16 and 17The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds, amid growing concern over the Omicron variant's ability to overcome immunity conferred by two shots.
Read more »